Boylan et al. compared p-NfH levels in plasma, serum and CSF in ALS patients, showing a significant association between higher concentrations and faster disease progression, evaluated as faster decline in ALS Functioning Rating Scale Revised (ALSFRS-R) [16]. Here, NEFH is linked to amyotrophic lateral sclerosis.